A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions like fibromyalgia and nerve pain, researchers found little convincing evidence of real benefit and flagged serious side effects such as delusions and nausea. The lack of data on whether it reduces depression or opioid use adds to the uncertainty.
source https://www.sciencedaily.com/releases/2025/08/250818102944.htm
Everything announced at the Xbox Partner Preview March 2026 — SEGA, Xbox
Game Pass, Xbox Play Anywhere, and more
-
Another Xbox Partner Preview showcase is upon us, giving us a closer look
at new Xbox and PC games and updates coming from Microsoft's game dev
partners.
...
22 hours ago
No comments:
Post a Comment